Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer
Otolaryngology–Head and Neck Surgery · 2026-04 · 174 (4) · 1025-1038
DOI: 10.1002/ohn.70151 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, published online on 2026-01-31. Written by Mateo Useche and 9 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA. Major MEDLINE topics: Mouth Neoplasms, Carcinoma, Squamous Cell. Cited 1 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDCD NIH HHS.
Abstract (original language)
Objective
To understand temporal trends in presentation and survival among patients with early‐onset oral cavity squamous cell carcinoma (EO‐OCSCC). Study Design Retrospective cohort study.
Setting
National Cancer Database (NCDB), 2004 to 2022.
Methods
Adult patients younger than 50 years diagnosed with OCSCC in the NCDB. Annual case distributions by subsite, sex, and stage were modeled with logistic regression, reporting odds ratios (ORs) per calendar year over time. Kaplan‐Meier and Cox proportional hazards analyses assessed 5‐year overall survival (OS), stratified by age group, subsite, and stage.
Results
Among 178,140 OCSCC cases, 21,630 (12.1%) were EO‐OCSCC with median age of 44 years. Tongue was the most common subsite (66.9%) and increased over time (OR/year = 1.03; 95% CI, 1.02‐1.04). Female cases rose steadily (OR/year = 1.01; 95% CI, 1.01‐1.02), narrowing the male‐female gap. Advanced‐stage disease increased by 5% annually in tongue tumors and 3% in non‐tongue tumors. Five‐year OS was higher in tongue (73.7%) than non‐tongue tumors (61.5%, P < .001) and improved over time, with annual reductions in mortality risk of 1.1% for tongue and 1.9% for non‐tongue tumors. By age group, survival was highest for patients 20‐29 years and lowest for those 40‐49 years.
Conclusion
EO‐OCSCC is increasingly presenting as tongue primaries and in female patients, with a rising burden of advanced‐stage disease. Despite this unfavorable shift, survival has improved modestly across subsites, ages, and stages, underscoring the heterogeneity of EO‐OCSCC and the need for earlier detection and awareness.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
- Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
ORCID profiles: Mateo Useche
Funding
- NIDCD NIH HHS
Cite
APA
Useche, M., Alkhatib, H. H., Rodriguez, C. P., Shih, L., Liao, J. J., Panjwani, N., Futran, N., Marchiano, E., Ferrandino, R., & Barber, B. (2026). Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer. Otolaryngology–Head and Neck Surgery, 174(4), 1025-1038. https://doi.org/10.1002/ohn.70151
Vancouver
Useche M, Alkhatib HH, Rodriguez CP, Shih L, Liao JJ, Panjwani N, et al. Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer. Otolaryngology–Head and Neck Surgery. 2026;174(4):1025-1038. doi:10.1002/ohn.70151
BibTeX
@article{Useche2026,
author = {Useche, Mateo and Alkhatib, Hosam H and Rodriguez, Cristina P and Shih, Lauren and Liao, Jay J and Panjwani, Neil and Futran, Neal and Marchiano, Emily and Ferrandino, Rocco and Barber, Brittany},
title = {Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early‐Onset Oral Cavity Cancer},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {174},
number = {4},
pages = {1025--1038},
doi = {10.1002/ohn.70151}
}
EUVIMED